Empress Therapeutics Funding: $50M Raised, Series A (2023)
Empress Therapeutics is based in Watertown, Massachusetts. It has raised $50M in total funding. Latest round: Series A. Backed by Flagship Pioneering.
Empress Therapeutics funding overview
Empress Therapeutics is based in Watertown, Massachusetts. Empress Therapeutics has raised $50M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in January 2023. The round record for Empress Therapeutics runs through 2023; nothing later has been disclosed. Investors on record include Flagship Pioneering.
Empress Therapeutics at a glance
Total raised
$50M
Latest round
Series A
Latest round date
January 2023
Headquarters
Watertown, Massachusetts
Notable investors
Flagship Pioneering
Frequently asked about Empress Therapeutics funding
How much has Empress Therapeutics raised?
Empress Therapeutics has raised $50M in total disclosed funding across the rounds on record.
Who has invested in Empress Therapeutics?
Flagship Pioneering are named among the investors backing Empress Therapeutics.
What was the latest Empress Therapeutics funding round?
The most recent disclosed round is a Series A, announced in January 2023.
Where is Empress Therapeutics based?
Empress Therapeutics is based in Watertown, Massachusetts.
When did Empress Therapeutics last raise?
The last disclosed Empress Therapeutics round closed in January 2023 at Series A.
Every Empress Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Watertown at a similar stage.
